During May 2021, we have published 2 new Cochrane reviews and one Cochrane review update in Issue 5, 2021 of the Cochrane Database of Systematic Reviews.
- Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD012972. DOI: 10.1002/14651858.CD012972.pub2.
- Anton-Vazquez V, Hine P, Krishna S, Chaplin M, Planche T. Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD013235. DOI: 10.1002/14651858.CD013235.pub2
- Gleave K, Lissenden N, Chaplin M, Choi L, Ranson H. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD012776. DOI: 10.1002/14651858.CD012776.pub3.
Throughout 2021, we will continue to add publications to our CIDG and READ-It websites regularly. Do continue to check our websites for updates and follow us on Twitter:
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise.
The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals